It is a challenge to develop the optimum dosage form of poorly water-soluble drugs and to target them due to limited bioavailability, intra and inter subject variability. In this investigation, mucoadhesive microemulsion of curcumin was developed by water titration method taking biocompatible components for intranasal delivery and was characterized. Nasal ciliotoxicity studies were carried out using excised sheep nasal mucosa. in vitro release studies of formulations and PDS were performed. Labrafil M 1944 CS based microemulsion was transparent, stable and nasal non-ciliotoxic having particle size 12.32±0.81nm (PdI=0.223) and from kinetic modeling, the release was found to be Fickian diffusion for mucoadhesive microemulsion.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467848PMC
http://dx.doi.org/10.4103/0975-7406.94148DOI Listing

Publication Analysis

Top Keywords

mucoadhesive microemulsion
12
kinetic modeling
8
formulation kinetic
4
modeling curcumin
4
curcumin loaded
4
loaded intranasal
4
intranasal mucoadhesive
4
microemulsion
4
microemulsion challenge
4
challenge develop
4

Similar Publications

Technological Strategies Applied to Pharmaceutical Systems for Intranasal Administration of Drugs Intended for Neurological Treatments: A Review.

AAPS PharmSciTech

November 2024

Postgraduate Program in Pharmaceutical Sciences, Laboratory of Research and Development of Drug Delivery Systems, Department of Pharmacy, State University of Maringa, Maringa, PR, Brazil.

The complexity of treating neurological diseases has meant that new strategies have had to be developed to deliver drugs to the brain more efficiently and safely. Intranasal drug delivery is characterized by its ease of administration, safety, and rapid delivery directly from the nose to the brain. Several strategies have been developed to improve the delivery of drugs to the brain via nasal administration.

View Article and Find Full Text PDF
Article Synopsis
  • Limited solubility of miconazole nitrate (MN) is a key factor in its low effectiveness against candidiasis, prompting a study to create a microemulsion (ME) and temperature-triggered in situ gel for enhanced delivery.
  • Researchers conducted various tests, including solubility studies and the construction of pseudo-ternary phase diagrams to optimize the formulation, ultimately selecting tea tree oil, lavender oil, tween 80, and propylene glycol for the ME.
  • The resulting gel formulation (MG1) showed optimal characteristics like gelation temperature, viscosity, and a significant increase in antifungal activity compared to existing MN products, alongside no irritation in animal tests.
View Article and Find Full Text PDF

Review of Intranasal Active Pharmaceutical Ingredient Delivery Systems.

Pharmaceuticals (Basel)

September 2024

Department of Chemical and Pharmaceutical Engineering, Mendeleev University of Chemical Technology of Russia, Miusskaya pl. 9, 125047 Moscow, Russia.

Article Synopsis
  • Increased focus on intranasal delivery systems for both local and systemic treatment, including CNS disorders and vaccines.
  • The nasal cavity's unique anatomy is beneficial for delivering active pharmaceutical ingredients (APIs), but challenges in the delivery process exist.
  • Various micro- and nanosystems, like liposomal systems and polymer particles, are being researched to enhance the effectiveness of nasal preparations for different diseases.
View Article and Find Full Text PDF

Neurodegenerative disorder refers to malfunctioning of neurons their degradation leading to death of neurons. Among various neurodegenerative disorders APHD (Alzheimer's, Parkinson's, and Huntington's Disease) are particularly concerning due to their progressive and debilitating nature. The therapeutic agent used for treatment and management of APHD often show unsatisfactory clinical outcome owing to poor solubility and limited permeability across blood brain barrier (BBB).

View Article and Find Full Text PDF

The OphthalMimic is a 3D-printed device that simulates human ocular conditions with artificial lacrimal flow, cul-de-sac area, moving eyelid, and a surface to interact with ophthalmic formulations. All tests with such a device have used a continuous artificial tear flow rate of 1 mL/min for 5 min. Here, we implemented protocol variations regarding the application time and simulated tear flow to increase the test's discrimination and achieve reliable performance results.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!